Search research articles
Contact Us
Filters
Showing results (241-250 of 303) with videos related to
Page
of 31
Sort By:
Arthritis Research & Therapy
|
September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity
Joan Wither, Yong-chun Cai, Sooyeol Lim, et al.
Biology
|
April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Blood
|
February 27, 2016
4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells
Seongseok Yun, Nicole D Vincelette, Katherine L B Knorr, et al.
Leukemia Research
|
July 1, 2019
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction
Bryan C Hambley, Kelly J Norsworthy, Jagar Jasem, et al.
Blood
|
January 18, 2011
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
Judith E Karp, B Douglas Smith, Linda S Resar, et al.
Blood Advances
|
August 20, 2020
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
Heather J Symons, Marianna Zahurak, Yilin Cao, et al.
Leukemia Research
|
September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
Kelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 2, 2019
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
Shannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Cancer Research
|
June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
Steven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
The Journal of Rheumatology
|
January 30, 2010
Clinical and serologic factors associated with lupus pleuritis
Shikha Mittoo, Allan C Gelber, Carol A Hitchon, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 303) with videos related to
Sort By:
Page
of 31
Arthritis Research & Therapy
|
September 12, 2008
Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity
Joan Wither, Yong-chun Cai, Sooyeol Lim, et al.
Biology
|
April 3, 2021
<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
Andrew Y Li, Sarah M Kashanian, Bryan C Hambley, et al.
Blood
|
February 27, 2016
4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells
Seongseok Yun, Nicole D Vincelette, Katherine L B Knorr, et al.
Leukemia Research
|
July 1, 2019
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction
Bryan C Hambley, Kelly J Norsworthy, Jagar Jasem, et al.
Blood
|
January 18, 2011
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias
Judith E Karp, B Douglas Smith, Linda S Resar, et al.
Blood Advances
|
August 20, 2020
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults
Heather J Symons, Marianna Zahurak, Yilin Cao, et al.
Leukemia Research
|
September 5, 2017
Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature
Kelly J Norsworthy, Amy E DeZern, Hua-Ling Tsai, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 2, 2019
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide
Shannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.
Cancer Research
|
June 17, 2006
Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms
Steven D Gore, Stephen Baylin, Elizabeth Sugar, et al.
The Journal of Rheumatology
|
January 30, 2010
Clinical and serologic factors associated with lupus pleuritis
Shikha Mittoo, Allan C Gelber, Carol A Hitchon, et al.
Page
of 31